Denise Booker
About Denise Booker
Denise Booker serves as the Senior Director of International Regulatory Affairs at AlloVir, where she has worked since 2020. With a strong background in regulatory affairs and extensive experience in global regulatory strategies, she supports the development of virus-specific T-cell immunotherapies.
Work at AlloVir
Denise Booker has served as the Senior Director of International Regulatory Affairs at AlloVir since 2020. In this role, she is responsible for managing global regulatory filing plans and strategies for international markets. She ensures that advocacy, transparency, and compliance are integral components of strategic regulatory planning and submissions management. Additionally, she supports enterprise regulatory strategies specifically for AlloVir's pipeline of virus-specific T-cell immunotherapies.
Previous Experience at Merck
Prior to her current position, Denise Booker held multiple roles at Merck. She worked as an Associate Principal Scientist in Regulatory Affairs from 2015 to 2017, and as Director of Regulatory Affairs International for Oncology from 2017 to 2020. Her tenure at Merck also included positions in Global Regulatory Operations, Data Management, and as a Relationship Manager in Vendor Strategy & Management. Overall, she accumulated over 16 years of experience at Merck.
Education and Expertise
Denise Booker earned her Master of Science (MS) in Quality Assurance/Regulatory Affairs from Temple University School of Pharmacy, completing her studies from 1997 to 1999. She also holds a Bachelor of Science (B.S.) in Chemistry from Chestnut Hill College, which she obtained from 1990 to 1994. Her educational background supports her extensive expertise in clinical assay development and external vendor management, as well as her comprehensive understanding of the drug development process.
Background in Regulatory Affairs
Denise Booker's career in regulatory affairs spans several key roles and responsibilities. She has extensive experience in managing global regulatory filing plans and strategies for international markets. Her industry experience encompasses the entire drug development process, from bench to market, allowing her to navigate complex regulatory landscapes effectively. This background positions her as a knowledgeable leader in the field of regulatory affairs.